2019 Archived Content

Analytics & Impurities

Traditional biologics, new biotherapeutics modalities and biosimilars are flooding discovery and development pipelines. Thus, analytical function is rapidly evolving, demanding high-throughput and high-resolution tools, focused biomolecular and biophysical assays, and rapid analytical and impurity profiling strategies. The Analytics & Impurities pipeline features in-depth perspectives on the latest developments and most critical steps in characterization of biologics, stability issues arising from particles, impurities, immunogenicity, protein aggregates and their impact on stability and safety of biopharmaceuticals.

Characterization of Biotherapeutics
Detection and Characterization of Particulates and Impurities
Protein Aggregation and Emerging Analytical Tools